Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardinal HealthLTS:0HTG -1.44%74 3-Year EPS without NRI Growth Rate is 23.70% as of Jun. 2026, which is 98% above its 10-year median of 12.00. GuruFocus rates LTS:0HTG with a GF Score™ of 74/100 and a GF Value™ of $152.64 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 102 Medical Distribution companies, Cardinal Health ranks better than 81.37% on this metric.
During the past 12 months, Cardinal Health's average EPS without NRI Growth Rate was 32.90% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 23.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 15.70% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 6.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Cardinal Health was 73.00% per year. The lowest was -20.20% per year. And the median was 12.00% per year.
Cardinal Health (LTS:0HTG) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Cardinal Health 3-Year EPS without NRI Growth Rate Related Terms
LTS:0HTG vs COR, HSIC, MCK: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Distribution subindustry, Cardinal Health's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health 3-Year EPS without NRI Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Cardinal Health's 3-Year EPS without NRI Growth Rate falls into.
Cardinal Health 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 23.70% mean?
Cardinal Health (LTS:0HTG) has a 3-Year EPS without NRI Growth Rate of 23.70% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Cardinal Health and its competitors. This is 98% above median its historical median of 12.00. According to the industry distribution chart, Cardinal Health ranks #19 out of 102 companies in the Medical Distribution industry, placing it in the top 18.6%.
Is Cardinal Health's 3-Year EPS without NRI Growth Rate too high?
Cardinal Health's current 3-Year EPS without NRI Growth Rate of 23.70% is 98% above median its 10-year median of 12.00. The Medical Distribution industry median 3-Year EPS without NRI Growth Rate is 3.10. Cardinal Health's value of 23.70% is 664.5% above this industry median. Based on the distribution chart, Cardinal Health ranks #19 out of 102 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cardinal Health has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's 3-Year EPS without NRI Growth Rate compare to COR and HSIC?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #19 out of 102 companies for 3-Year EPS without NRI Growth Rate. This places Cardinal Health in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 3.10. Cardinal Health's value of 23.70% is 664.5% above this benchmark. While the company's 10-year median is 12.00 vs. the industry median of 3.10, Cardinal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Distribution company?
The median 3-Year EPS without NRI Growth Rate among Medical Distribution companies is 3.10, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current 3-Year EPS without NRI Growth Rate of 23.70% is 664.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Cardinal Health and its competitors. For the Medical Distribution industry, the median 3-Year EPS without NRI Growth Rate is 3.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current 3-Year EPS without NRI Growth Rate is 23.70%, which is 98% above median its own 10-year median of 12.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (LTS:0HTG) is currently considered Significantly Overvalued. The stock's GF Value™ is $152.64, compared to a current price of $233.06 — trading 52.7% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 23.70%, which is 98% above median its 10-year median of 12.00 and 664.5% above the Medical Distribution industry median of 3.10. Cardinal Health's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Cardinal Health (LTS:0HTG), the current 3-Year EPS without NRI Growth Rate is 23.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (LTS:0HTG) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $233.06 is trading 52.7% above its estimated GF Value™ of $152.64.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for LTS:0HTG:
3-Year EPS without NRI Growth Rate: 23.70% (98% above median its 10-year median of 12.00)
GF Value™: $152.64 vs. price of $233.06 (52.7% above fair value)
Industry Position: 664.5% above the Medical Distribution median (#19 of 102)
No single metric tells the full story. See the LTS:0HTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
74GF Score
Get the complete analysis for LTS:0HTG
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0HTG has been successfully added to your 
